Your browser doesn't support javascript.
loading
TP53 Exon 5 Mutation Indicates Poor Progression-Free Survival for Patients with Stage IV NSCLC.
Feng, Huijing; Xu, Huiru; Shi, Xiuhuan; Ding, Guobin; Yan, Cihui; Li, Linhan; Jian, Zuoyi; Yang, Xuejing; Guo, Hongxia; Li, Feng; Zhang, Junping; Ren, Xiubao.
Afiliación
  • Feng H; Cancer Institute and Hospital, Department of Immunology, Tianjin Medical University, 300060 Tianjin, China.
  • Xu H; National Clinical Research Center for Cancer, 300060 Tianjin, China.
  • Shi X; Key Laboratory of Cancer Prevention and Therapy, 300060 Tianjin, China.
  • Ding G; Tianjin's Clinical Research Center for Cancer, 300060 Tianjin, China.
  • Yan C; Key Laboratory of Cancer Immunology and Biotherapy, 300060 Tianjin, China.
  • Li L; Department of Thoracic Oncology, Cancer Center, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, 030032 Taiyuan, Shanxi, China.
  • Jian Z; Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 430030 Wuhan, Hubei, China.
  • Yang X; Cancer Institute and Hospital, Department of Immunology, Tianjin Medical University, 300060 Tianjin, China.
  • Guo H; National Clinical Research Center for Cancer, 300060 Tianjin, China.
  • Li F; Key Laboratory of Cancer Prevention and Therapy, 300060 Tianjin, China.
  • Zhang J; Tianjin's Clinical Research Center for Cancer, 300060 Tianjin, China.
  • Ren X; Key Laboratory of Cancer Immunology and Biotherapy, 300060 Tianjin, China.
Front Biosci (Landmark Ed) ; 28(7): 147, 2023 07 24.
Article en En | MEDLINE | ID: mdl-37525904

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Front Biosci (Landmark Ed) Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Front Biosci (Landmark Ed) Año: 2023 Tipo del documento: Article País de afiliación: China